公司資料
Sensei Biotherapeutics 股價、新聞與催化劑
- 股票代碼:
- SNSE
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
13.85 USD (+6.54%)
收盤價
最後更新: 2026年6月15日
21.6M USD
市值
股價為何變動
Current closing-price context is not available for SNSE.
公司概覽
業務概覽
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer. Its platform aims to create differentiated cancer treatments through immune modulation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Sensei sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, immune-mechanism validation, and the ability to build a durable cancer franchise.
生技產業定位
Sensei is a catalyst-driven immuno-oncology name whose stock responds to early clinical and translational progress.
未來催化劑
- The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities. The most useful line from the latest update is First patient dosed in Phase 1b/2 trial of PIKTOR in HR+/HER2- advanced breast cancer Topline Phase 2 data in patients with advanced endometrial cancer expected in second half.... That should keep the program at the center of the company narrative for now.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。